Global

Highlights Stocks jumped earlier this week on encouraging news on the vaccine front. While we remain positive on equities over a 12-month horizon, we would stress five vaccine-related risks that stock market investors should be cognizant of. First, immunizing most of the world’s population could prove logistically challenging, especially in light of widespread skepticism about the safety of the vaccine. Second, the virus could mutate in a way that undercuts the efficacy of the vaccine, as recent unsettling news from Denmark demonstrates. Third, vaccine optimism could, ironically, lead to weaker economic growth in the near term, even if it does lead to stronger growth in the medium and longer term. Fourth, improved prospects for a vaccine could reduce urgency around extending fiscal support. Fifth, bond yields could rise further in anticipation of an earlier return to full employment. This could pose a headwind for equities – especially growth stocks. V Is For Vaccine Stocks rallied this week on news that Pfizer’s trial of its Covid-19 vaccine had apparently immunized more than 90% of test participants. Such a high efficacy rate is on par with that of the childhood measles and smallpox vaccines, and well above the typical 30%-to-50% success rate for the seasonal flu (Chart 1). Chart 1Efficacy Rates Of Seasonal Flu Vaccines Are Not Exceptionally High Pfizer’s vaccine leverages messenger RNA (mRNA) technology developed by its German partner, BioNTech. The new technology is similar to the one being deployed by US-based Moderna. It uses synthetic genetic material to coax the body into producing antibodies, thus bypassing the time-consuming process of formulating a vaccine using dead or weakened forms of the actual pathogen. Pfizer began manufacturing the vaccine well before it knew it would work. It expects to ask the US Food and Drug Administration for emergency authorization to begin distribution by the end of November. If all goes well, the company will have 15-to-20 million doses available by the end of this year and enough to inoculate the entire US population by mid-2021. Ten other vaccines are in late-stage trials. It is widely expected that most of them will prove to be safe and effective (Chart 2). Chart 2When Will A Vaccine Become Available? Five Risks This week’s vaccine news is certainly encouraging, and it does pave the way for a rapid rebound in economic activity next year. Thus, we remain bullish on stocks over a 12-month horizon. Nevertheless, investors should be cognizant of five vaccine-related risks: Table 1Skepticism Over Vaccines Has Been Growing Over The Past Two Decades Risk #1: Immunizing most of the world’s population is likely to prove logistically challenging, especially in light of widespread public skepticism about the safety of the vaccine Pfizer’s version of the vaccine needs to be refrigerated at -70°C, making it difficult to store and transport. It will also need to be administered twice over the course of 21 days (Merck is the only company working on a single-dose vaccine). All this will require health care providers to keep track of who received which dose of the vaccine and at which time. There is also considerable uncertainty about how long immunity from the vaccine will last. Pfizer is cautiously optimistic that it will be over a year, but the truth is that no one really knows. Vaccinating most of the global population repeatedly year in, year out could prove to be challenging. In addition, the rollout of the vaccine could face widespread public skepticism. Even before the pandemic struck, confidence in the safety of vaccines was waning in the United States. A Gallup study published on January 14th of this year revealed that the share of Americans who thought it was important to get their children vaccinated fell from 94% in 2001 to 84% in 2019. The drop was particularly steep among Americans with children under the age of 18 (Table 1).1 Ten percent of Americans believed the thoroughly debunked claim that vaccines cause autism, while 46% were “unsure.”2  Things do not appear to have improved since then. According to a recent Pew Research Center survey conducted in September, only 51% of Americans said they would probably or definitely take the vaccine, down from 72% in May (Chart 3). The most common reason given for refusing to take it was “concern about side effects.” Chart 3Many Americans Are Wary Of A Covid-19 Vaccine The fact that all the Covid-19 vaccines under development do seem to produce worse side effects than the typical flu vaccine could amplify fears that “the cure is worse than the disease.” We could end up in a “You first; oh no you first; I insist you first” predicament where most people try to avoid being first in line to receive a vaccine. Still, it is important to keep in mind that not everyone has to be vaccinated for the virus to be eradicated. Suppose that 70% of the population needs to be inoculated to simulate herd immunity. If the vaccine works nine out of ten times, then 0.7/0.9 or 78% of the population would have to receive the vaccine. The true number could end up being less than that because some people who survived Covid will have antibodies for a while even if they remain unvaccinated. There is also tentative evidence that a few lucky souls may be naturally immune to the disease, perhaps by having contracted seasonal coronavirus colds in the past.3 Furthermore, both government and corporate policy are likely to push people to get vaccinated. For better or for worse, governments may require that children present vaccination certificates before being admitted to school. Airlines could also demand such certificates before one is allowed to travel. Insurance companies could cut off coverage for those who fail to get vaccinated. At any rate, it is difficult to see governments pursuing lockdown measures after a vaccine is widely available. The prevailing view will be that anyone who voluntarily chooses to remain unvaccinated cannot hold others hostage. Risk #2: The virus could mutate in a way that undercuts the efficacy of the vaccine Unlike most RNA-based viruses, coronaviruses carry an error-correction mechanism in their genomes. While this confers certain advantages to this family of viruses, it also means that they tend to mutate more slowly than notorious shape-shifters like the common flu. Nevertheless, there is plenty of evidence that SARS-CoV-2, the virus that causes Covid-19, has mutated since it first emerged in China.4 Viruses tend to become less lethal but more contagious over time. This is not surprising. A virus that kills its host will also kill itself. The speed at which a virus mutates is partly a function of how much of it is in circulation. The more copies of the virus there are, the larger the number of adaptive mutations there are likely to be. The fact that SARS-CoV-2 has spread to virtually every corner of the earth raises the risk that it will readily produce strains that the current batch of vaccines is not equipped to target. Unfortunately, this may not just be an idle threat. In Denmark, 12 people have already been infected with a novel strain of the virus that first emerged from mink farms. Although the data is still sketchy, the virus seemingly jumped from humans to minks early on in the pandemic, mutated within the mink population, and then jumped back to humans. The mutation appears to have altered the virus’s spike proteins. These are the proteins that the virus uses to gain entry into human cells. They are also the proteins that Pfizer’s vaccine is targeting. It is still not clear if the mutated strain will be vaccine-resistant, but governments are not taking any chances. The UK barred entry to travelers from Denmark on November 5th. Other countries may follow suit. Risk #3: Vaccine optimism could lead to weaker economic growth in the near term The release of the results of Pfizer’s vaccine trial comes at a time when the number of new confirmed global cases has reached record highs (Chart 4). The latest wave of the pandemic has hit Europe especially hard. European governments have responded by tightening lockdown measures (Chart 5). Euro area GDP is likely to contract in the fourth quarter. Chart 4The Number Of New Cases Continues To Rise Globally Chart 5Some Lockdown Measures Have Been Reintroduced While the development of a vaccine is good news for the economy in the medium-to-long term, it is not clear if it will help growth in the near term. On the one hand, vaccine optimism could cause firms to invest more, while curbing household precautionary savings. This would boost aggregate demand. On the other hand, vaccine optimism could prompt people to make even more effort to avoid getting sick. If you take shelter under a tree during an unforeseen rainstorm, you’re better off staying put until the storm passes... provided, of course, that the rainfall does not last too long. But what if you check your phone and see that the rain is supposed to fall uninterrupted for the next three days? That is a long time to spend under a tree. At that point, you are better off proceeding ahead. After all, you are going to get wet in any case. Chart 6Commercial Bankruptcy Filings Remain In Check The same logic applies to the pandemic. If you can avoid getting sick by hunkering down for a few more months until a vaccine becomes available, it is well worth doing so. However, if the prospects for a vaccine or effective treatment are poor, it makes less sense to hide from the rest of the world. Chances are you are going to get sick anyway. Risk #4: Improved prospects for a vaccine could reduce urgency around extending fiscal support So far, the pandemic has left only limited scarring on the global economy. For example, according to the American Bankruptcy Institute, corporate bankruptcies are lower now than they were this time last year (Chart 6). The same is true for delinquency rates on most consumer loans (Table 2).   Table 2A Snapshot Of Consumer Delinquencies Many economies have displayed resilience so far thanks to ample fiscal and monetary support. In Europe and Japan, the combination of wage subsidies and job retention programs has kept unemployment from rising significantly (Chart 7). The unemployment rate rose rapidly in the US, Canada, and Australia early on in the pandemic, but has since declined. In the US, there are now fewer than two unemployed workers per job opening (Chart 8). It took the US over five years to reach that point following the Global Financial Crisis. Chart 7Ample Fiscal Policy Has Helped Shield The Labor Market From The Pandemic Chart 8The Labor Market Is In A Better Place Now Compared To The Great Recession   The risk is that fiscal policy support will be withdrawn before lockdown measures can be lifted. While such a risk cannot be ignored, two things should help mitigate it. First, fiscal hawks are more likely to support a temporary stimulus package that lasts a few months rather than an open-ended support scheme that may be needed indefinitely. Second, public opinion still very much favors maintaining stimulus. According to a recent NY Times/Siena College poll, 72% of voters support a hypothetical $2 trillion stimulus package that extends emergency unemployment insurance benefits, distributes direct cash payments to households, and provides financial support to state and local governments (Table 3). Such a package is basically what the Democrats are proposing. Strikingly, when this package is described in non-partisan terms, even the majority of Republicans are in favor of it. Risk #5: Bond yields could rise further in anticipation of an earlier return to full employment If a premature tightening of fiscal policy is unlikely to sink the stock market, could higher bond yields do the trick? Central banks will not raise interest rates for the next few years. However, rate expectations could still rise further along the forward curve if investors believe that a vaccine will allow the output gap to close earlier than previously anticipated. Chart 9Policy Rate Expectations Remain Below Pre-Pandemic Levels Investors expect US short-term rates to average only 1.25% in 2027-28. While this is higher than prior to the vaccine announcement, it is still well below where rate expectations were at the start of the year. Long-dated rate expectations are similarly below pre-pandemic levels in most other economies (Chart 9). Upward revisions to where policy rates will be later this decade could lift long-term bond yields. Higher yields, in turn, could raise the discount rate that stock market investors use to calculate the present value of future cash flows. This might lead to lower equity prices. The valuation of growth companies, whose earnings may not be realized for many years to come, is especially vulnerable to changes in discount rates. Despite the threat posed from rising bond yields, we suspect that the actual impact on equity prices will be fairly modest. There are three reasons for this. First, any increase in bond yields will probably occur alongside rising inflation expectations. As such, real yields may not increase that much. Conceptually, it is real yields, rather than nominal yields, that matter for equity valuations. Second, provided that higher yields are reflective of stronger growth, earnings estimates are likely to drift up. Rising profits will dampen the impact of higher bond yields on equity valuations. Third, central banks have both the tools, and just as importantly, the inclination to keep bond yields from spiking as they did during the 2013 “taper tantrum.” These tools include QE, aggressive forward guidance, and if necessary, yield curve control strategies. Investment Conclusions The path to ending the pandemic is likely to be a bumpy one. Nevertheless, the balance between risk and reward still favors overweighting equities versus bonds over the next 12 months. Within the equity portion of a portfolio, investors should reallocate funds from US stocks to overseas markets and from growth stocks to value stocks. Growth stocks benefited from the pandemic and from falling bond yields, but will suffer as yields rise modestly from current levels and investors shift exposure to stocks that will benefit from the reopening of economies. Chart 10Stronger Global Growth Tends To Be A Headwind For The Dollar... While Dollar Weakness Usually Bodes Well For Non-US Stocks Chart 11EM Stocks Are Cheap As a countercyclical currency, the trade-weighted US dollar is likely to weaken further in 2021. Non-US stocks typically outperform their US peers when the dollar depreciates (Chart 10). A weaker dollar will provide an additional boost to emerging market equities, given that many EMs have a lot of dollar-denominated debt. Assuming Joe Biden becomes president, a de-escalation of the trade war would also help emerging markets, particularly China. Lastly, EM equities are still quite cheap based on cyclically-adjusted earnings (Chart 11). Peter Berezin Chief Global Strategist peterb@bcaresearch.com   Footnotes 1 Attitudes towards vaccines have shifted notably over the past two decades. The following survey captures the erosion of trust towards vaccines: RJ Reinhart, “Fewer in U.S. Continue to See Vaccines as Important,” Gallup, January 14, 2020. 2 One of the most widely known parental concerns about the safety of vaccines is linked to the hypothesis that the measles-mumps-rubella (MMR) vaccine causes autism. Since this hypothesis was published more than three decades ago, dozens of researchers have presented studies showing that the original claims are critically flawed. The evidence provided by the scientific community dismisses the link between vaccines and autism. Please see Jeffrey S. Gerber and Paul A. Offit, “Vaccines and Autism: A Tale of Shifting Hypotheses,” National Center for Biotechnology Information; and “Vaccines and Autism,” Children’s Hospital of Philadelphia, May 7, 2018. 3 There has been much debate over why some people are affected more than others by Covid-19. While much attention is given to personal characteristics (such as age, weight, or the presence of chronic illnesses), researchers have also investigated the possibility that prior exposure to coronaviruses have helped some to obtain a certain degree of natural immunity to Covid-19. Please see Yaqinuddin, Ahmed, “Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities,” Medical hypotheses, vol. 144 110049, (30 June, 2020). 4 One of the latent fears since the emergence of Covid-19 has been the possibility that it will mutate as it spreads. The following study suggests that different strains of the virus have been evolving on different continents, although it is not clear to what extend these mutations could affect treatment and immunization efforts. Please see Pachetti, M., Marini, B., Benedetti, F. et al., “Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant,” Journal of Translational Medicine, 18:179 (2020). Global Investment Strategy View Matrix Current MacroQuant Model Scores

Highlights According to betting markets, Joe Biden is likely to become the 46th US president, with the Republicans maintaining control of the Senate. Such a balance of power could produce less fiscal stimulus than any of the other possible outcomes that were in play on Tuesday. Nevertheless, public opinion still favors a more expansionary fiscal policy. There is also an outside chance that Republicans in the Senate and Democrats in the House could craft a “grand bargain” that raises spending while making Trump’s corporate tax cuts permanent. The combination of continued easy monetary policy, modestly looser fiscal policy, and progress on a vaccine should be enough to keep global growth on an above-trend path next year. Bank shares have been the big losers since the election, but should start to outperform as yield curves re-steepen, worries about soaring bad loans subside, and lending growth outpaces bleak expectations. Investors should remain overweight global equities versus bonds. Be prepared to increase exposure to value stocks when clearer evidence emerges that the latest wave of the pandemic is cresting. Another Election Rollercoaster Last week, we highlighted that BCA’s geopolitical quant model was predicting a much closer election than most pundits were expecting. This indeed turned out to be the case. For a brief while on Tuesday night, betting markets were giving Donald Trump a greater than 75% chance of being re-elected. Unfortunately for the president, the good news did not last long. As more mail-in ballots and ballots cast in large urban areas were counted, the needle began to swing towards Joe Biden. At the time of writing, betting markets are giving Biden an 88% chance of becoming President. Trump still has a chance of winning, but assuming he loses Nevada, Michigan, and Wisconsin, he would need to win Pennsylvania, Arizona, and Georgia. That is a tall order. According to PredictIt, the latter three states are all leaning towards Biden (Chart 1). Chart 1The Distribution Of Electoral College Votes According To Betting Markets More positively for the GOP, the Republicans gained a net six seats in the House of Representatives, and held onto the Senate thanks to surprise victories for their candidates in Maine and North Carolina. That said, the Senate could still revert to Democratic hands depending on the final vote tally in Georgia, North Carolina, and Alaska; PredictIt assigns a 22% probability to the Democrats taking the Senate. Moreover, even if they fall short this time around, the Democrats still have a chance of winning a 50-seat de facto majority in the Senate if both Georgia races go to a run-off election on January 5. Stimulus In Peril? Assuming that Republicans maintain their majority in the Senate, tax hikes will remain off the table. This is good for stocks. Joe Biden would also lower the temperature on trade tensions with China. This, too, is good for stocks. Conversely, the odds of a major fiscal stimulus package have dropped. Donald Trump is not averse to big spending programs. In contrast, the Republicans in the Senate have rejected calls for a large stimulus bill. With Joe Biden as President, Republican senators would have even less incentive to give the Democrats what they want. Nevertheless, there are three reasons to think that Republicans will agree on a new stimulus bill. First, the economy needs it. While US growth should remain reasonably firm in the fourth quarter, this is only because households were able to build up some savings earlier this year which they can now draw on. As Chart 2 shows, since April, labor earnings have only grown one-third as much as personal spending. Transfer income has also plunged, resulting in a renewed drop in savings. Once households run out of accumulated savings, there is a risk that they will cut back on spending. Second, government borrowing rates remain extremely low by historic standards. Real rates are negative across the entire yield curve (Chart 3). Chart 2Savings Have Dropped Since April As Transfers Declined Chart 3Real Rates Are Negative Across The Entire Yield Curve   Third, and perhaps most politically salient, public opinion favors more expansionary fiscal policy. About 72% of voters support a hypothetical $2 trillion stimulus package that extends emergency unemployment insurance benefits, distributes direct cash payments to households, and provides financial support to state and local governments (Table 1). Such a package is basically what the Democrats are proposing. It is noteworthy that when this package is described in non-partisan terms, even the majority of Republicans are in favor of it. Table 1Strong Support For Stimulus All this suggests that Republicans will accede to a medium-sized stimulus bill in the neighbourhood of $700 billion-to-$1 trillion in order to avoid being perceived as stingy and obstructionist. Senate Majority Leader Mitch McConnell noted on Wednesday that getting a deal done was “job one.” While not our base case, a significantly larger bill is also possible. Most Republicans are not opposed to bigger budget deficits per se. It is increased social spending that they do not like. Budget deficits in the service of tax cuts are perfectly acceptable to the majority of Republicans. This raises the possibility that Republicans in the Senate and Democrats in the House could strike a grand bargain that raises spending while also promising additional tax relief. Most of Trump’s corporate tax cuts expire in 2025. A sizeable stimulus bill that makes these tax cuts permanent while increasing long-term spending on infrastructure, health care, education, and other Democratic priorities could still emerge from a divided Congress.   Wall Street Versus Main Street If one needed any more proof that what is good for Wall Street is not necessarily good for Main Street, the last three trading days provided it. The S&P 500 is up 6% since Monday’s close, spurred on by the reassurance that corporate taxes will not rise. In contrast, the 10-year bond yield has fallen 8 basis points on diminished prospects for a big stimulus package. The drop in bond yields since the election has raised the present value of corporate cash flows, leading to higher equity valuations. Growth companies have benefited disproportionately from falling bond yields. In contrast to value companies, investors expect growth companies to generate the bulk of their earnings far in the future. This makes their valuations highly sensitive to changes in discount rates. It is not surprising that tech shares – the FAANGs in particular – soared following the election (Chart 4). Chart 4Growth Equities Benefited Disproportionately From A Post-Election Drop In Yields A Bottom For The Big Banks? Bank shares tend to be overrepresented in value indices. Unlike tech, banks normally lose out when bond yields fall. As Chart 5 shows, net interest margins have collapsed for banks this year as bond yields have cratered. The drop in yields since the election has further punished bank shares. Chart 5Bank Net Interest Margins Have Collapsed As Bond Yields Have Cratered This Year Chart 6Commercial Bankruptcy Filings Remain In Check Yet, as our earlier discussion suggests, bond yields could rise again if the US Congress delivers more stimulus than currently expected. This would help banks, while potentially taking some of the wind from the sails of tech stocks. The combination of further fiscal easing and a vaccine next year could help banks in another way. If the global economy bounces back, banks would suffer fewer loan defaults. The biggest US banks have set aside more than $60 billion to cover potential loan losses. They have done so even though commercial bankruptcies have declined so far this year (Chart 6). A stronger economy would allow banks to release some of those provisions back into earnings.   Bank Regulation Is Not A Major Worry Anymore Wouldn’t the potential benefits to banks from more fiscal support and higher bond yields be outweighed by a greater regulatory burden under a Biden administration? Probably not. For one thing, a Republican Senate could block legislation that expanded regulation. Moreover, Biden hails from Delaware, a state that derives more than a quarter of its GDP from the finance and insurance sectors. He was only one of two Democrats on the Senate Judiciary Committee to vote in favor of the 2005 bankruptcy bill that made it more difficult for households to discharge their debts. It should also be stressed that most of the regulatory reforms that the Democrats sought after the financial crisis have already been encoded in the Dodd-Frank Act. The Act was passed during the Obama administration. While the Trump administration did water down some of its provisions, the changes were modest and had bipartisan support. Big Banks Are More Resilient Than Small Ones Today, US banks are better capitalized than they were in the years leading up to the financial crisis (Chart 7). The largest banks – the so-called Systemically Important Financial Institutions (SIFIs) – are required to hold an additional capital buffer, which arguably makes them even safer. Unlike the smaller regional banks, the SIFIs have only modest exposure to the troubled commercial real estate sector. As my colleague Jonathan LaBerge has documented, big banks have only 6% of their assets tied up in commercial real estate compared to 25% for smaller banks (Table 2). Chart 7US Banks: Better Capitalized Today Than Right Before The Financial Crisis Table 2Most US Commercial Real Estate Loans Are Held By Small Banks The largest US banks have more exposure to residential real estate than to commercial real estate. The US housing market has been firing on all cylinders recently. Single-family housing starts were up 24% year-over-year in September. Building permits and home sales are near cycle highs. The S&P/Case-Shiller 20-city home price index rose 5.2% in August, up from 4.1% in July. The FHFA index surged 8.1% in August over the prior year. Homebuilder confidence hit a new record in October (Chart 8). Homebuilder stocks are up more than 20% versus the broad market this year. Chart 8US Housing Market: Firing On All Cylinders According to TransUnion, consumer delinquencies have been trending lower across most loan categories (Table 3). Notably, the 60-day delinquency rate on residential mortgages stood at 1% in September, down from 1.5% the same month last year. Table 3A Snapshot Of Consumer Delinquencies The Forbearance Time Bomb? Some investors have expressed concern that various pandemic-related forbearance programs are distorting the delinquency data. Reassuringly, that does not appear to be the case. Summarizing the results from the latest round of earnings calls with top bank executives, BCA’s Chief US Investment Strategist Doug Peta wrote: “Last week’s calls assuaged our concerns … It now appears that consumer requests for forbearance at the outset of the COVID-19 outbreak were analogous to businesses’ credit line draws: exercises of emergency options that turned out not to be necessary, and are on their way to being unwound with little ado.”1 Banks Are Cheap From a valuation perspective, relative to the broad market, US banks trade at one of the largest discounts on record on both a price-to-book and price-to-earnings basis (Chart 9). Earnings estimates are also starting to move in the banks’ favor. Relative 12-month forward earnings estimates for US banks are trending higher even against the tech sector (Chart 10). This largely reflects the expectation that bank earnings will grow more quickly than other sectors in 2021/22. Chart 9Bank Stocks Are Cheap Chart 10Bank Earnings Estimates Are Catching Up   A Few Words About Global Banks Chart 11Euro Area Banks Have Fared Especially Badly Since The GFC Chart 12Banks: A Low Bar For Success Banks in a number of markets outside the US face greater structural challenges than their US counterparts. Most notably, euro area bank earnings remain well below their pre-GFC highs (Chart 11). That said, investors are not exactly expecting European bank profits to recover to their glory days anytime soon. Chart 12 shows that if euro area bank EPS were to simply go back to last year’s levels, banks would trade at 5.4-times earnings. This implies a very low bar for success. Investment Conclusions Stocks have run up a lot over the past few days on fairly weak breadth. A short-term pullback would not be surprising. Nevertheless, investors should remain overweight global equities versus bonds over a 12-month horizon. The combination of ongoing fiscal and monetary support, together with a vaccine, will buoy global growth. As Chart 13 shows, it’s rare for stocks to underperform bonds when the global economy is strengthening. Chart 13Stocks Rarely Underperform Bonds When The Global Economy Is Strengthening Chart 14Value Stocks Typically Do Well When Economic Activity Is Picking Up   Value stocks typically do well when economic activity is picking up (Chart 14). That said, we are less sure about when the inflection point in the value/growth trade will arrive. As we have noted before, the “pandemic trade” benefits growth stocks, while the “reopening trade” benefits value stocks. For now, the number of new infections has not shown signs of peaking in either the US or Europe (Chart 15). Investors should continue monitoring the daily Covid data and be prepared to increase exposure to value stocks when clearer evidence emerges that the latest wave of the pandemic is cresting.   Chart 15The Number Of New Cases Continues To Rise Globally... But Mortality Rates Are Lower Than Earlier This Year Chart 16The Dollar Is A Countercyclical Currency As a countercyclical currency, the dollar should weaken next year as policy remains accommodative and pandemic risks recede (Chart 16). EM Asian currencies are especially appealing. A hiatus in the trade war should allow the Chinese yuan to strengthen even further. This will drag other regional currencies higher. Peter Berezin Chief Global Strategist peterb@bcaresearch.com Footnotes 1  Please see US Investment Strategy Weekly Report, “The Big Bank Beige Book, October 2020,” dated October 19, 2020. Global Investment Strategy View Matrix Current MacroQuant Model Scores

Your feedback is important to us. Please take our client survey today. Highlights A surge in the number of Covid cases worldwide and the failure of the US Congress to forge a stimulus deal has cast doubt on the “reflation trade.” European governments have responded to rising case counts with a flurry of restrictions. While not quite as extreme as those introduced in March, the new lockdown rules will still weigh on growth over the coming months. The good news is that progress on a vaccine continues, with the vast majority of experts expecting one to be widely available within the next 12 months. The degree to which US fiscal policy will turn stimulative again depends on the outcome of the election. A “blue wave” would produce the most fiscal stimulus, while a Biden victory coupled with continued Republican control of the Senate would produce the least. However, even in the latter scenario, popular support for further fiscal easing – including among Republican voters – will help catalyze a deal. The near-term picture for stocks is murky. Nevertheless, investors should remain overweight global equities on a one-to-two year horizon, while shifting exposure to non-US markets and value stocks. Worries About The Sanguine Narrative Chart 1The Number Of New Cases Continues To Rise Globally... But Mortality Rates Are Lower Than Earlier This Year Equities recovered some of their losses on Thursday, but remain down on the week. Investors have become increasingly concerned about the viability of the so-called reflation trade. Stocks rallied in the spring and summer on hopes that the worst of the pandemic was over and that fiscal stimulus would continue to prop up employment and spending. Now, both assumptions are being challenged. The number of coronavirus cases continues to rise worldwide (Chart 1). In both Europe and the US, the daily tally of confirmed new cases exceeds its March peak. The only saving grace is that the number of deaths has not risen by as much as many had feared. Governments are reacting to rising case counts by tightening social distancing rules. The German government ordered bars, clubs, theaters, concert halls, museums, cinemas, sit-down restaurants, and most athletic facilities to close in November. Hotels will no longer be able to cater to tourists, while private meetings of over 10 people will be prohibited. Along the same lines, France has imposed a comprehensive nationwide lockdown until December 1st, with President Macron stating the nation has been “overpowered by a second wave.” Earlier this week, the Italian government announced that bars and restaurants must close by 6pm. News reports indicate that the UK government is preparing a slate of new restrictions. While the most recent lockdowns in Europe are not as severe as those introduced earlier this year, they will still weigh on growth over the coming months. There has been less movement toward shuttering the US economy in response to what is now the third wave of the pandemic. This may be partly because the latest cluster of cases has been fairly localized, concentrated mainly in the central north of the country. So far at least, the heavily populated south and coastal states have been spared the brunt of the wave. However, if more states start seeing rising case counts, stricter restrictions could be introduced across most of the country. Fiscal Food Fight Meanwhile in Washington, both Republican and Democrat leaders conceded that there will be no stimulus deal before the election. House Speaker Nancy Pelosi said that Trump had “failed miserably” in his handling of the pandemic, the economy, and everything else. The President, for his part, claimed that “Nancy Pelosi is only interested in bailing out badly-run, crime-ridden Democrat cities and states,” adding that “After the election, we will get the best stimulus package you have ever seen.” Of course, whether Trump can fulfill his “best ever” pledge depends on the outcome of the election. As we discuss below, there is considerable uncertainty over how the political landscape in Washington will look after November 3rd. Nevertheless, most roads still lead to more stimulus. The Election Homestretch Chart 2Opinion Polls Favor The Democrats ... Chart 3... As Do Betting Markets As the US election campaign winds down, both opinion polls and betting markets suggest that Joe Biden will become the next president while the Democrats will regain control of the Senate (Chart 2 and Chart 3). That said, this is not the only possible outcome. As this handy applet from The Cook Political Report makes clear, small changes in the assumptions about either voter preferences or turnout can shift the results significantly. For example, Trump saw his approval among African Americans rise from 25% last week to around 40% this week according to Rasmussen’s daily tracking poll. Such a large move in this one particular poll undoubtedly overstates the true magnitude of the trend, but it is consistent with the analysis that Matt Gertken and BCA’s geopolitical team has done showing that Trump has reduced the Democrats’ lead among minority voters relative to 2016. If Trump can improve his vote share among black voters from the meager 8% he received in the 2016 election to 11% this time around, it would be enough to tip the entire race in his favor. The quant model developed by BCA’s Geopolitical Strategy service, which elevates recent economic data over polling numbers in its computations, gives Donald Trump a 51% probability of remaining president and an equivalent chance of the Republicans picking up the Senate (Chart 4). Subjectively, Matt thinks Trump has a 45% chance of winning. While lower than his quant model, this is still above the 39% probability that betting markets assign to a Trump victory (Chart 5). Chart 4BCA’s Quant Model Points To Trump Victory And Favors Republicans In The Senate Chart 5Election Odds: BCA's Geopolitical Team Versus Betting Markets What Would The Stock Market Prefer? From the equity perspective, stocks would likely rise if Trump won and the Democrats took over the Senate. If re-elected, President Trump would block any efforts to raise taxes or tighten business regulations. However, unlike a number of Republican senators, Trump is not averse to increasing government spending. Earlier this month, the President proposed a $1.8 trillion stimulus bill. Senate Republicans have offered only $500 million for pandemic relief. The stock market would welcome both easier fiscal policy and the implicit guarantee that taxes will not rise. The stock market would also be content with a Democratic sweep, provided it did not result in a blowout victory. A narrow Senate victory would still allow the Democrats to pass a fiscal stimulus bill through the creative use of the “reconciliation process.” However, it would curb the influence of the party’s more left-leaning members. Several Democratic senators have expressed reservations about scrapping the filibuster rule which requires a supermajority of 60 votes to pass most non-budget related legislation. If the filibuster rule is eliminated, it would make it easier to strengthen antitrust law, tighten labor and environmental standards, and raise the minimum wage, all of which could dampen corporate profits. Investors would likely deem a continuation of the existing political configuration in Washington – where Donald Trump remains president and the Republicans maintain a slim majority in the Senate – as neutral for stocks. On the one hand, such an outcome would take the prospects of tax hikes off the table. On the other hand, it could prolong the trade war and extend the stalemate over a stimulus bill. Lastly, stock market investors might frown upon a scenario involving a Biden victory and continued Republican control of the Senate. Of all the scenarios mentioned above, the prospects for a major stimulus package would be lowest for this configuration of political outcomes. This is because Republican senators would have even less incentive to accede to more spending if Joe Biden, rather than Donald Trump, were pressing for it. Still, even in this scenario, it is unlikely that the US will shift to fiscal austerity anytime soon. As Table 1 shows, 72% of voters support the broad outline of the Democrat’s stimulus proposal. Strikingly, even most Republican voters support it, at least when the question is posed in nonpartisan terms. This suggests that a Democratic House could still find a way to strike a stimulus deal with a Republican Senate, perhaps by agreeing to further cut taxes in exchange for more government spending. Table 1Strong Support For Stimulus Investment Conclusions While governments have understandably tightened restrictions to control the latest surge in Covid cases, they are unlikely to fully revert to the extreme measures taken in March. Back then, there was considerable uncertainty over how fatal the virus was, with estimates for the mortality rate ranging from 0.5%  to over 5%. The latest research suggests that the true number is near the bottom of that range, and perhaps even below it.1 Progress continues to be made on a vaccine. Close to 95% of professional forecasters surveyed by The Good Judgement Project expect a vaccine to be widely available within the next 12 months (Chart 6). Chart 6When Will A Vaccine Become Available? Chart 7Non-US Equities Tend To Outperform Their US Peers When Global Growth Is Improving And The Dollar Is Weakening The combination of a vaccine and further fiscal support against a backdrop of ultra-easy monetary policy should be enough to lift global equities by about 15% towards the end of 2021. While the near-term picture for stocks is murky, investors should remain overweight global equities over a one-to-two year horizon. As a countercyclical currency, the US dollar is poised to weaken next year. Typically, non-US stocks outperform when global growth is strengthening and the dollar is weakening (Chart 7). Value stocks also tend to do better in such macro environments (Chart 8). Once the latest wave of the pandemic crests, as it inevitably will, investors should look to shift their equity portfolios from stocks that benefited from lockdowns towards those that will benefit from reopenings.   Chart 8 (I)... Ditto For Value Stocks Versus Growth Stocks Chart 8 (II)... Ditto For Value Stocks Versus Growth Stocks Peter Berezin Chief Global Strategist peterb@bcaresearch.com Footnotes 1 A recent systematic review of literature found that the Covid-19 infection fatality rate (IFR) stood at 0.7%. Similarly, in September, the Centers for Disease Control and Prevention (CDC) published age-specific IFRs in its Covid-19 Planning Scenarios. The population-weighted average of the CDC’s “best estimate” suggests a 0.7% IFR. Please see “COVID-19 Pandemic Planning Scenarios,” Centers for Disease Control and Prevention, Updated September 10, 2020; and Gideon Meyerowitz-Katz, and Lea Merone, “A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates,” International Journal of Infectious Diseases, September 29, 2020. Global Investment Strategy View Matrix Current MacroQuant Model Scores

Highlights Global risk assets have more downside in the near term. The US dollar is primed to rebound. Without major fiscal stimulus in the US, the upside in the greenback will be substantial. China’s business cycle recovery will continue but Chinese stocks and China-related plays are over-hyped and will experience a setback. For equity and credit investors, we recommend maintaining a neutral allocation to EM versus their DM counterparts. Feature Global risk assets have been in a twilight zone. On the one hand, there has been enormous uncertainty related to the US elections, the US fiscal stimulus and the impact of renewed social mobility restrictions on economic activity, especially in Europe. On the other hand, ultra-accommodative central banks, zero or negative interest rates on risk-free investments and the possibility of positive news on the COVID-19 vaccine front have until recently precluded a carnage in global risk assets. What will be the path going forward? We believe the risk-off period in global markets will continue in the near run, i.e., there will be a dusk before a sunrise. Hence, investors should maintain dry powder at the moment. Several negative outcomes have a non-trivial probability of occurring over the very near term. Chiefly these include a contested US presidential election or a Republican Senate under a Biden presidency acting as a constraint on large fiscal stimulus. Chart I-1The US Needs $1.5tn (7.4% Of GDP) Of Fiscal Stimulus In 2021 To Have A Neutral Fiscal Thrust Needless to say, without a large fiscal stimulus package, the US is facing a fiscal cliff. According to the US Congressional Budget Office, the fiscal thrust will be negative 7.4% of GDP in 2021 if no further stimulus is enacted (Chart I-1). The fiscal thrust is the change in the cyclically-adjusted budget deficit. Even if the cyclically-adjusted budget deficit as a share of GDP remains the same, fiscal thrust will be zero. Hence, to achieve a positive fiscal thrust in the US, the fiscal stimulus must be greater than 7.4% of GDP or above $1.5 trillion.  Even though Congress eventually approves a large fiscal package, there is a risk that the economy will slip in the interim. To emphasize, we do not mean there will be no fiscal stimulus. The point is that a large fiscal package is possible only if markets riot. With equity and credit markets still richly priced relative to their fundamentals, the carnage in global risk assets will likely continue.     With equity and credit markets still richly priced relative to their fundamentals, the carnage in global risk assets will likely continue. Chart I-2The US: Lower Inflation Expectations, Higher Real Rates And A Stronger Dollar In the absence of a large US fiscal package and amid falling oil prices, US break-even inflation expectations will drop and the TIPS (real) yields will bounce in the near term (Chart I-2). A rebound in TIPS (real) yields will induce a bounce in the US dollar (Chart I-2, bottom panel).  Provided that the primary risks presently stem from DM rather than Chinese growth, we recommend maintaining a neutral allocation to EM within respective global equity and credit portfolios. Why not overweight EM versus DM? First, the rebound in the greenback will weigh on EM financial markets. Second, outside China, Korea and Taiwan, EM fundamentals are poor. Net-net, odds of EM out- and under-performance versus DM are, for now, balanced. China: Peak Stimulus, Equities And Commodities China’s business cycle recovery is intact. However, Chinese equities have become fully priced and are at risk of a setback (in absolute terms) along with global share prices. Notably, there are several elements that could trigger a meaningful setback in Chinese stocks. First, the money and credit impulses are about to peak. The top panel of Chart I-3 shows that changes in commercial banks’ excess reserves ratio lead the credit impulse by about six months. The drop in the excess reserves ratio since May foreshadows the top in the private credit impulse. Interbank rates – shown inverted in the bottom panel of Chart I-3 – point to an apex in the narrow money (M1) impulse. Authorities have been shrinking commercial banks’ excess reserves at the PBoC since May/June.  Tightening liquidity conditions in the banking system have led to higher interbank rates as well as government and corporate bond yields. Higher borrowing costs will weigh on money and credit growth. Second, the loan approval index of the PBoC banking survey has rolled over (Chart I-4). This implies that bank loan origination will subside going forward. Chart I-3China: Money/Credit Impulses Are At An Apex Chart I-4China: Loan Growth To Moderate Finally, fiscal stimulus is also peaking. Chart I-5 shows that the issuance of local government bonds is set to dwindle in the coming months. A peak in stimulus does not herald an immediate end of the recovery in the business cycle. China’s combined credit and fiscal spending impulse leads the business cycle by about nine months (Chart I-6). Therefore, even as the credit and fiscal spending impulse reaches an apex, the Chinese mainland’s economic activity will stay firm in H1 2021. Consequently, corporate profits will continue to recover. Chart I-5China: Fiscal Stimulus Is Peaking Chart I-6China: The Economy Will Continue Recovering What do all these imply for share prices? In periods when borrowing costs rise along with accelerating profit growth/improving net EPS revisions, share prices could still advance (Chart I-7). Hence, peak stimulus is not a sufficient reason to turn negative on share prices. Chart I-7China: Share Prices (ex-TMT), EPS Expectations And Corporate Bond Yields That said, there are some signs that the Chinese equity market is overbought and over-hyped, making it vulnerable: A major IPO often marks a top in an asset class. Chart I-8 illustrates that Goldman Sachs’ IPO in 1999 preceded the secular top in US equities, IPOs of KKR and Blackstone in 2007 took place before the US credit bubble and the LBO boom unraveled; and finally, Glencore, the largest commodity trading house, went public in 2011 at the very peak of the secular bull market in commodities. In this respect, will Ant Group’s upcoming IPO mark a major top in Chinese or new economy stocks? Time will tell. Chart I-9 illustrates that Chinese IPO booms were historically associated with equity market tops. The current surge in Chinese IPOs – in various jurisdictions including China, Hong Kong, and the US – is a symptom of an over-hyped market. Chart I-8A Major IPO Often Marks The Top in Respective Asset Classes Chart I-9China: Booming IPOs = An Equity Market Top? Finally, new economy stocks in both the US and China have risen by about 20-fold since January 2010. Both in terms of duration and magnitude, their rallies are identical to the bull market in the Nasdaq 100 index in the 1990s (Chart I-10). The striking similarity with those episodes as well as current euphoria among investors about FAANG and Chinese new economy stocks warrant caution. In regard to commodities, in recent months we have been arguing that China is entering a commodity destocking cycle following the major restocking cycle that occurred in April-August. As Chinese imports of key commodities temporarily diminish due to destocking, commodities prices will relapse. Importantly, investor sentiment and net long positions in some key commodities are very elevated, suggesting overbought conditions (Chart I-11). Chart I-10FAANG And Tencent Have Been Tracking The Trajectory Of Nasdaq 100 In The 1990s Chart I-11Investors Are Very Bullish On Copper Critically, global mining stocks have been dropping since early September and are signaling a relapse in industrial metals prices (Chart I-12). In brief, commodity prices and commodity plays remain vulnerable. Chart I-12Global Mining Stocks Point To A Relapse In Industrial Commodities Prices Bottom Line: Marrying the positive outlook for China’s business cycle on the one hand with an  impending potential correction in global stocks, the peak in Chinese stimulus and signs of Chinese equity investor euphoria, we conclude that the risk-reward profiles of Chinese stocks and China-related plays in absolute terms are unattractive. That said, we continue recommending overweighting Chinese stocks within an EM equity portfolio. From a cyclical perspective, Chinese corporate profits will outperform EM and DM corporate earnings because China has dealt with the pandemic much better than almost all other countries. An Update On Currencies And Local Fixed-Income We have been shorting a basket of EM currencies – BRL, CLP, ZAR, TRY, KRW and IDR – against an equally-weighted basket of the euro, CHF and JPY. This strategy remains intact. However, we believe the US dollar is primed to stage a major rebound, in general, and versus EM currencies, in particular. Therefore, US dollar-based investors should hedge their currency risk or short the same EM currency basket versus the greenback. In EM local fixed-income markets, we have been receiving 10-year swap rates but have not recommended owning cash domestic bonds because of currency risk. We continue to recommend investors receive 10-year swap rates in the following markets: Mexico, Colombia, Russia, China, India and Korea. We have also been recommending long positions in domestic bonds in certain frontier markets like Egypt, Ukraine, and Pakistan. The global risk-off phase will cause their currencies to relapse versus the US dollar, raising the possibility that local bond yields will rise. Therefore, investors who are long these markets should close these positions.   Arthur Budaghyan Chief Emerging Markets Strategist arthurb@bcaresearch.com Equities Recommendations Currencies, Credit And Fixed-Income Recommendations